Clinical Trial Update: A Study to Compare Tablets and Capsules of Orforglipron (LY3502970) in Healthy Participants Who Are Obese or Overweight [Phase 1]

View source ↗

Summary

A Phase 1 study compared tablets and capsules of orforglipron (LY3502970) in healthy participants who are obese or overweight, and the trial status is completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Orforglipron (orforglipron)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Healthy, Obese | Phase 1 | Status: COMPLETED